GlassScriptPhysician profile
Judit A Cope
NPI 1033346176
$5,685.33
in general payments reported to CMS, 2019-2025
33 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 88% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $448 · 2021: $336 · 2022: $1,044 · 2023: $798 · 2024: $981 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,728 · Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,727.64 |
| Food and Beverage | $1,152.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,481.63 | 2020-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $891.00 | 2024 | Iovera |
| Collegium Pharmaceutical, INC. | $316.48 | 2019-2023 | Belbuca |
| Merz Pharmaceuticals, LLC | $240.99 | 2021-2023 | Xeomin |
| Merz North America, INC. | $200.49 | 2019-2020 | |
| Si-Bone, INC. | $179.82 | 2020-2023 | |
| Allergan, INC. | $159.88 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $158.62 | 2019-2020 | |
| Daiichi Sankyo INC. | $125.50 | 2019 | |
| Fidia Pharma USA INC. | $83.66 | 2019-2022 | |
| Nevro Corp. | $81.48 | 2020-2023 | Senza |
| Abbott Laboratories | $79.61 | 2019-2022 | |
| Medtronic, INC. | $68.35 | 2024 | Intellis Adaptivestim |
| Bausch Health US, LLC | $66.89 | 2019 | |
| Biodelivery Sciences International, INC. | $61.37 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $54.90 | 2023 | Seglentis |
| Zyla Life Sciences, INC. | $42.00 | 2019 | |
| Pfizer INC. | $41.20 | 2019 | |
| Radius Health, INC. | $38.10 | 2022 | |
| Orthofix Medical, INC. | $37.14 | 2019-2021 | |
| Pacira Therapeutics, INC. | $35.27 | 2020 | |
| Abbvie INC. | $32.23 | 2019-2022 | |
| Horizon Therapeutics Plc | $29.73 | 2020-2022 | |
| Vericel Corporation | $22.98 | 2022 | |
| Endo Pharmaceuticals INC. | $20.92 | 2022 | |
| Bioventus LLC | $20.70 | 2022 | |
| Medtronic USA, INC. | $20.40 | 2019 | |
| Orthogenrx INC. | $19.23 | 2019 | |
| Ermi LLC | $18.86 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.84 | 2022 | |
| Amneal Pharmaceuticals LLC | $13.38 | 2022 | |
| Lilly USA, LLC | $12.50 | 2022 | |
| Kaleo, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judit Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.